[1] OGASAWARA K,YABE R,UCHIKAWA M,et al.Molecular genetic analysis of variant phenotypes of the ABO blood group system[J]. Blood,1996,88(7):2732-2737. [2] WANG C B,TANG Y C,ZHANG P P,et al.Detection and phenotype analysis of a novel Ael blood group allele[J]. Vox Sang,2024,119(1):74-78. [3] SHAO L N,YANG Y C,XIA Y X,et al.Novel missense mutation c.797T>C (p.Met266Thr) gives rise to the rare B(A) phenotype in a Chinese family[J]. Vox Sang, 2024,119(4):383-387. [4] 杨乾坤,靳慧芳,吕先萍,等. CisAB血型的血清学鉴定及分子遗传学研究——附1例报告[J]. 中国输血杂志,2019,32(1):38-41. [5] 陆华,肖瑞卿,隆晓秋. 成人及新生儿红细胞表面ABH血型抗原强度的比较[J]. 重庆医学,2013,42(32):3904-3905. [6] POOLE J,DANIELS G.Blood group antibodies and their significance in transfusion medicine[J]. Transfus Med Rev,2007,21(1):58-71. [7] 李云燕,赵国胜,刘凤霞,等. 血液病所致ABO血型抗原减弱分析和处理对策[J]. 湖南师范大学学报(医学版),2023,20(4):83-86. [8] THURESSON B,HOSSEINI-MAAF B,HULT A K, et al.A novel B(weak) hybrid allele lacks three enhancer repeats but generates normal ABO transcript levels[J]. Vox Sang,2012,102(1):55-64. [9] SELTSAM A,WAGNER F F,GRÜGER D,et al. Weak blood group B phenotypes may be caused by variations in the CCAAT-binding factor/NF-Y enhancer region of the ABO gene[J]. Transfusion,2007,47(12):2330-2335. [10] ODA A,ISA K,OGASAWARA K,et al.A novel mutation of the GATA site in the erythroid cell-specific regulatory element of the ABO gene in a blood donor with the Am B phenotype[J]. Vox Sang,2015,108(4):425-427. [11] TAKAHASHI Y,ISA K,SANO R,et al.Presence of nucleotide substitutions in transcriptional regulatory elements such as the erythroid cell-specific enhancer-like element and the ABO promoter in individuals with phenotypes A3 and B3,respectively[J]. Vox Sang, 2014,107(2):171-180. [12] ROBB K P,COTECHINI T,ALLAIRE C,et al.Inflammation-induced fetal growth restriction in rats is associated with increased placental HIF-1α accumulation[J]. PLoS One,2017,12(4):e0175805. [13] ZHANG S S,WANG Y,LI J T,et al.miR-101 inhibits migration and invasion of trophoblast HTR-8/SVneo cells by targeting CXCL6 in preeclampsia[J]. Minerva Med,2021,112(2):302-303. |